Nearly 80 patients were screened for peripheral artery disease (PAD) at a recent Saturday morning outreach event held at the Hospital. “We found numerous people who needed some type of follow-up,” said interventional cardiologist Daniel Ice, MD. PAD affects approximately 17 million Americans. This common and potentially serious vascular disease occurs when arteries in the legs become clogged with fatty cholesterol deposits, reducing blood flow to the legs. “Patients with PAD are at a much higher risk of heart attack, stroke and death. But with early detection, PAD can be treated with lifestyle changes, medication, and many types of non-surgical procedures. Our dedicated team was glad to be able to provide a valuable Saturday morning free screening to the public.” 

Deborah Heart and Lung Center in Browns Mills, NJ is an 89-bed teaching hospital that specializes in the prevention, diagnosis, research, and treatment of heart, lung, and vascular diseases. Founded in 1922, Deborah has been a regional and nationally recognized leader throughout its 100-year history, during which time it has healed 2.3 million patients from every corner of the United States and 87 countries in the world. From performing the first open heart surgeries (adult and pediatric) in New Jersey, to running one of the highest volume left-ventricular assist device (LVAD) implant programs in the region, Deborah has stood at the forefront of medical innovation, all while never wavering from its founding mission “there is no price on life.” Deborah is consistently recognized as a leader in patient care from the Centers for Medicare and Medicaid Services, ranked among the top hospitals in New Jersey for patient satisfaction; holds a top-tier Society of Thoracic Surgeons rating which places Deborah among the best cardiac surgery programs in the country; and is designated a national Top Teaching Hospital by The Leapfrog Group. Deborah is an Alliance member of the Cleveland Clinic Heart, Vascular & Thoracic Institute.